iTeos Therapeutics, Inc. (ITOS) Tops Q1 EPS by 13c

iTeos Therapeutics, Inc. (NASDAQ: ITOS) reported Q1 EPS of ($0.80), $0.13 better than the analyst estimate of ($0.93).

For earnings history and earnings-related data on iTeos Therapeutics, Inc. (ITOS) click here.

You May Also Be Interested In

• Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Motorola Solutions (MSI) Declares $1.21 Quarterly Dividend; 1% Yield